Clinical Trial

ORION-8 A long term extension trial of the Phase III lipid-lowering trials to assess the effect of long term dosing of inclisiran given as subcutaneous injections in subjects with high cardiovascular risk and elevated LDL-C

Study Status:

Contact Information:

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose

The purpose of the study is to evaluate the efficacy, safety and long tolerability of long-term dosing of inclisiran in patient with atherosclerotic cardiovascular disease, hypercholesterolemia and elevated LDL-C (Bad Cholesterol)


Principal Investigator Mahesh Changlani, MD
Sponsor The Medicines Company
Type of Trial Interventional